Study on Protection of the Right to Health, Access to Medicines and the Construction of the Rule of Law for Medicine Patents
Journal Title: Annals of Bioethics & Clinical Applications - Year 2022, Vol 5, Issue 4
Abstract
The Access to Medicines is related to the basic rights of people's rights to life and health. It has been widely recognized by international conventions and has become a basic duty of the state to ensure and improve the level of citizens' access to medicines. At the same time, in the face of increasingly widespread uncertainties in modern society, building a fair and efficient legal system for medicines access is a necessary measure to promote citizens' trust in the government and maintain the legitimacy of power. In the conditions of 1.3 billion population and an unbalanced and inadequate economic development, China strives to ensure that its citizens’ medicines are economically affordable through continuous improvement of the legal system and arrangements, and to encourage local pharmaceutical companies to develop and manufacture better-quality medicines. On the premise of respecting the status of market players and property rights of pharmaceutical companies, China comprehensively uses diversified tools such as information, standards, market access, and competition law enforcement to establish a legal system for medicines accessibility from two channels: supply guarantee and price control. Particular attention is paid to the adjustment of the medical and social insurance and essential medicines systems. In recent years, China has focused on improving the pharmaceutical patent system, promoting the balanced development of local original research medicines and generic medicines, as well as the overall optimization and upgrading of the pharmaceutical industry through the protection of patent rights and appropriate restrictions. Driven by the economic and trade agreement reached between China and the United States in 2020, China's Patent Law will introduce a drug patent term extension system and a drug patent linkage system, and further improve the legal mechanism to encourage innovative activities of pharmaceutical companies.
Authors and Affiliations
Yang W, Hai Y* and Haitian M
Keywords
Related Articles
- EP ID EP745704
- DOI 10.23880/abca-16000245
- Views 33
- Downloads 0
Marriage, Sexual Privacy, and Sodomy Statutes in the World: A Case Analysis
According to the traditional Judeo-Christian moral and ethical standards, which conceive of sex in purely functional terms, i.e., for the purpose of procreation only. Now days the legislation criminalizing consensual ora...
Transformation of Agricultural Practices and Health Outcomes: An Empirical Investigation of Chronic Kidney Disease of unknown Etiology (CKDu) in Sri Lanka
The prevalence of chronic kidney disease of unknown etiology (CKDu) has significantly affected rural families, while creating many socio-economic problems in Sri Lanka. Extreme weather due to climatic change has produced...
The Use of AI in a Pandemic Emergence: A Biolegal Discourse in the International Arena
The pandemic has resulted in an emergency situation that has called into question not only health perspectives but also shared values and established rules. The critical question being how best to face up to this cultura...
Administrative Law and Sustainable and Inclusive Technologies in Face of the Hunger Pandemic
The United Nations (UN) is alerting about a hunger pandemic, far worse than COVID-19, because an increasing amount of people lack access to enough nutritious food.
The Question of the Genetic Identity of Individuals between National Law and the European Court of Human Rights
This work is focused on minors without genetic identity in (old and) new family models. In Europe, this situation generates hard conflicts between Internal Public Order and the so-called International Public Order . The...